药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mecasermin
Triptolide
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Triptolide.
Mecasermin
Guselkumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Guselkumab.
Mecasermin
Sirukumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sirukumab.
Mecasermin
Brodalumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brodalumab.
Mecasermin
Peficitinib
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Peficitinib.
Mecasermin
Voclosporin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Voclosporin.
Mecasermin
Pirarubicin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pirarubicin.
Mecasermin
Ravulizumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ravulizumab.
Mecasermin
Ixekizumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ixekizumab.
Mecasermin
Melengestrol
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Melengestrol.
Mecasermin
Tepoxalin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tepoxalin.
Mecasermin
Fluprednisolone
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluprednisolone.
Mecasermin
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Antilymphocyte immunoglobulin (horse).
Mecasermin
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Peginterferon beta-1a.
Mecasermin
Tixocortol
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tixocortol.
Mecasermin
Vilanterol
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vilanterol.
Mecasermin
Dinutuximab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dinutuximab.
Mecasermin
Blinatumomab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Blinatumomab.
Mecasermin
Vedolizumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vedolizumab.
Mecasermin
Obinutuzumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab.